Stock GRPH LENZ THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights LENZ Therapeutics, Inc. OTC Markets

Equities

GRPH

US52635N1037

Real-time Estimate Cboe BZX
Other stock markets
 01:34:42 2024-04-29 pm EDT 		5-day change 1st Jan Change
16.44 USD -26.17% Intraday chart for LENZ Therapeutics, Inc. -4.79% +21.37%
Apr. 15 Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target MT
Apr. 15 William Blair Starts LENZ Therapeutics With Outperform Rating MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LENZ Therapeutics Reports Positive Topline Data From Late-Stage Presbyopia Trials
MT
LENZ Therapeutics, Inc. Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials
CI
Lenz Therapeutics' eye disease drugs meet main goal of late-stage study
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LENZ Stock
  4. GRPH Stock
  5. News LENZ Therapeutics, Inc.
  6. Highlights